<DOC>
	<DOCNO>NCT03001440</DOCNO>
	<brief_summary>Branded bupropion hydrochloride product include ZYBAN WELLBUTRIN range approve treatment smoke cessation depressive disorder respectively . The Risk Evaluation Mitigation Strategy ( REMS ) ZYBAN initially approve 2010 consist Medication Guide timetable REMS assessment submission 18 month , 3 year 7 year date initial approval REMS . The present study 7-year REMS assessment evaluate subject ' understand potential serious risk neuropsychiatric adverse event associate use ZYBAN , WELLBUTRIN , WELLBUTRIN SR , WELLBUTRIN XL . The assessment 20-minutes Knowledge , Attitudes Behavior ( KAB ) survey conduct among approximately 125 subject currently use fill prescription brand bupropion product smoking cessation within 6 month prior survey administration . ZYBAN , WELLBUTRIN , WELLBUTRIN SR , WELLBUTRIN XL register trade mark GSK group company .</brief_summary>
	<brief_title>A 7-year Assessment Subject Understanding ZYBAN/ WELLBUTRIN Associated Risks</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Subjects currently use fill prescription ZYBAN , WELLBUTRIN , WELLBUTRIN SR , WELLBUTRIN XL smoke cessation within previous 6 month . ( Note : Branded bupropion hydrochloride product use confirmed series question within screener concern manufacturer information detail product label [ label medication container ] follow review photograph generic bupropion , ZYBAN , WELLBUTRIN , WELLBUTRIN SR WELLBUTRIN XL tablet type online via paper copy send invitation letter choose participate via phone ) 18 year age older Fluent English speaker ( telephone ) Consent take online survey survey administer via telephone interview Subjects take generic bupropion Subjects currently use fill prescription brand bupropion product depression alone Under 18 year age Previous participation brand bupropion hydrochloride survey , determine via selfreport survey</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>REMS</keyword>
	<keyword>Smoking cessation</keyword>
	<keyword>WELLBUTRIN</keyword>
	<keyword>ZYBAN</keyword>
	<keyword>Neuropsychiatric adverse event</keyword>
</DOC>